2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis (†)

Amyloid light chain (AL) amyloidosis is characterized by misfolded light chain (LC) (amyloid) deposition in various peripheral organs, leading to progressive dysfunction and death. There are no regulatory agency–approved treatments for AL amyloidosis, and none of the available standard of care appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Renz, Mark, Torres, Ronald, Dolan, Philip J., Tam, Stephen J., Tapia, Jose R., Li, Lauri, Salmans, Joshua R., Barbour, Robin M., Shughrue, Paul J., Nijjar, Tarlochan, Schenk, Dale, Kinney, Gene G., Zago, Wagner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152553/
https://www.ncbi.nlm.nih.gov/pubmed/27494229
http://dx.doi.org/10.1080/13506129.2016.1205974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152553/
https://www.ncbi.nlm.nih.gov/pubmed/27494229
http://dx.doi.org/10.1080/13506129.2016.1205974

Ejemplares similares